Xarelto
Brand Name: Xarelto
Generic Name: Rivaroxaban
Active
Registration Number
DR-XY49359
Dosage Form
Film-Coated Tablet
Issuance Date
March 26, 2025
Expiry Date
March 25, 2030
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength2.5 mg
PackagingPP/Alu Blister Pack x 10's (Box of 10's)
Classification
C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Antithrombotic (Direct Factor Xa Inhibitor)
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
RivaroxabanActive
Monograph: Rivaroxaban